Synergy CHC Corp. announced its financial results for the second quarter ended June 30, 2025, on August 14, 2025. The company reported its tenth consecutive quarter of profitability, a significant milestone. Net income for Q2 2025 reached $1.5 million, a 125% increase compared to $655.2 thousand in Q2 2024.
Revenue for the second quarter was $8.1 million, up 1% from $8.0 million in Q2 2024, and included $1.4 million in new license revenue. Gross margin expanded to 76.7% in Q2 2025, up from 69.5% in the prior-year quarter, primarily driven by the higher-margin license revenue. Earnings per share increased by 86% to $0.17, compared to $0.09 in Q2 2024.
Operating expenses rose 16% to $4.6 million, mainly due to costs associated with being a public company, but income from operations still grew 2.5% to $1.62 million. EBITDA for the quarter was $3.80 million, a 136% increase from $1.61 million in Q2 2024.
The company also reported a strengthened balance sheet, with cash and cash equivalents at $1.5 million as of June 30, 2025, up from $687.9 thousand at December 31, 2024. Working capital improved significantly to a surplus of $12.4 million, compared to a $1.12 million deficit at the end of 2024. Cash used in operating activities for the first half of 2025 decreased to $899.7 thousand from $1.1 million in H1 2024.
These results reflect disciplined execution and profitable growth, supported by strategic initiatives such as expanding the global footprint of the FOCUSfactor brand through a licensing agreement in Turkey. The company also completed a $20 million debt refinancing, which extends its maturity profile and enhances financial flexibility.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.